Previous studies have shown that ameloblastomas have an elevated expression of MMP-2, MMP-9, and vascular endothelial growth factor (VEGF), and are void of or have an abnormal expression of E-cadherin and TIMP-2 [11-14]. The gene discussed is TIMP2; the disease is ameloblastoma.